BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10945101)

  • 1. Paradoxical pattern of haematological risk with clozapine.
    Gillman K
    Br J Psychiatry; 2000 Jul; 177():88. PubMed ID: 10945101
    [No Abstract]   [Full Text] [Related]  

  • 2. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine-Associated Neutropenia and Agranulocytosis.
    Andres E; Mourot-Cottet R
    J Clin Psychopharmacol; 2017 Dec; 37(6):749-750. PubMed ID: 29040154
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
    Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
    Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haematological toxicity of clozapine and some other drugs used in psychiatry.
    Nooijen PM; Carvalho F; Flanagan RJ
    Hum Psychopharmacol; 2011 Mar; 26(2):112-9. PubMed ID: 21416507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine, agranulocytosis, and benign ethnic neutropenia.
    Rajagopal S
    Postgrad Med J; 2005 Sep; 81(959):545-6. PubMed ID: 16143678
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutropenia and Agranulocytosis in Chinese Patients Prescribed Clozapine.
    Lau KL; Yim PH
    East Asian Arch Psychiatry; 2015 Dec; 25(4):164-7. PubMed ID: 26764291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
    Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
    Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
    Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
    J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
    [No Abstract]   [Full Text] [Related]  

  • 10. Comment on "lithium and clozapine rechallenge: a retrospective case analysis".
    Esposito D
    J Clin Psychiatry; 2007 Apr; 68(4):635; author reply 635. PubMed ID: 17474825
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland.
    Ingimarsson O; MacCabe JH; Haraldsson M; Jónsdóttir H; Sigurdsson E
    BMC Psychiatry; 2016 Dec; 16(1):441. PubMed ID: 27955666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Late-onset neutropenia with clozapine.
    Duggal HS; Singh I
    Can J Psychiatry; 2006 Feb; 51(2):125; author reply 125-6. PubMed ID: 16989111
    [No Abstract]   [Full Text] [Related]  

  • 13. [Granulocytopenia while using clozapine: continuing or stopping treatment].
    Bogers JP
    Tijdschr Psychiatr; 2007; 49(8):575-9. PubMed ID: 17694491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic benign neutropenia/agranulocytosis associated with non-clozapine antipsychotics.
    Vila-Rodriguez F; Tsang P; Barr AM
    Am J Psychiatry; 2013 Oct; 170(10):1213-4. PubMed ID: 24084822
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.
    van der Weide K; Loovers H; Pondman K; Bogers J; van der Straaten T; Langemeijer E; Cohen D; Commandeur J; van der Weide J
    Pharmacogenomics J; 2017 Oct; 17(5):471-478. PubMed ID: 27168101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse reaction reporting and new antipsychotics.
    Kerwin R
    Lancet; 1993 Dec; 342(8885):1440. PubMed ID: 7504153
    [No Abstract]   [Full Text] [Related]  

  • 17. Haematological monitoring in psychiatry.
    Latif Z
    Ir J Med Sci; 2010 Jun; 179(2):317. PubMed ID: 19711017
    [No Abstract]   [Full Text] [Related]  

  • 18. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
    Munro J; O'Sullivan D; Andrews C; Arana A; Mortimer A; Kerwin R
    Br J Psychiatry; 1999 Dec; 175():576-80. PubMed ID: 10789357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.